Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin (Q44120776)

30 November 2017

Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin (English)

1 reference

30 November 2017

0 references

8

Dewey G McCafferty

1 reference

30 November 2017

Predrag Cudic

1

1 reference

30 November 2017

Douglas C Behenna

2

1 reference

30 November 2017

James K Kranz

3

1 reference

30 November 2017

Ryan G Kruger

4

1 reference

30 November 2017

A Joshua Wand

5

1 reference

30 November 2017

Yuri I Veklich

6

1 reference

30 November 2017

John W Weisel

7

1 reference

30 November 2017

1 August 2002

1 reference

30 November 2017

Chemistry and Biology

1 reference

30 November 2017

9

1 reference

30 November 2017

8

1 reference

30 November 2017

897-906

1 reference

Hospital-acquired infections: diseases with increasingly limited therapies

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Antimicrobial-drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Bactericidal activity of ramoplanin against antibiotic-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Inhibition of peptidoglycan biosynthesis by ramoplanin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Enduracidin, a New Antibiotic. VIII. Structures of Enduracidins A and B

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Enduracidin, an inhibitor of cell wall synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Inhibition of cell wall synthesis by the antibiotics diumycin and janiemycin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Additional antibiotic inhibitors of peptidoglycan synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Janiemycin, a new peptide antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Constitution and Solution Conformation of the Antibiotic Mersacidin Determined by NMR and Molecular Dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Synergy and duality in peptide antibiotic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

3D structure of ramoplanin: a potent inhibitor of bacterial cell wall synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Synthesis of P(1)-Citronellyl-P(2)-alpha-D-pyranosyl pyrophosphates as potential substrates for the E. coli undecaprenyl-pyrophosphoryl-N-acetylglucoseaminyl transferase MurG.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

The structural role of sugars in glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Total synthesis of the ramoplanin A2 and ramoplanose aglycon

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

Retention of native-like structure in an acyclic counterpart of a beta-sheet antibiotic.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900191-6

7 January 2021

10.1016/S1074-5521(02)00191-6

Identifiers

DOI

1 reference

30 November 2017

1 reference